FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3198398959> ?p ?o ?g. }

• W3198398959 endingPage "4524" @default.
• W3198398959 startingPage "4524" @default.
• W3198398959 abstract "The purpose of this study was to determine the frequency of clinically actionable treatment-relevant germline pharmacogenomic variants in patients with cancer and assess the real-world clinical utility of universal screening using whole-exome sequencing in this population. Cancer patients underwent research-grade germline whole-exome sequencing as a component of sequencing for somatic variants. Analysis in a clinical bioinformatics pipeline identified clinically actionable pharmacogenomic variants. Clinical Pharmacogenetics Implementation Consortium guidelines defined clinical actionability. We assessed clinical utility by reviewing electronic health records to determine the frequency of patients receiving pharmacogenomically actionable anti-cancer agents and associated outcomes. This observational study evaluated 291 patients with cancer. More than 90% carried any clinically relevant pharmacogenetic variant. At least one disease-relevant variant impacting anti-cancer agents was identified in 26.5% (77/291). Nine patients with toxicity-associated pharmacogenomic variants were treated with a relevant medication: seven UGT1A1 intermediate metabolizers were treated with irinotecan, one intermediate DPYD metabolizer was treated with 5-fluorouracil, and one TPMT poor metabolizer was treated with mercaptopurine. These individuals were more likely to experience treatment-associated toxicities than their wild-type counterparts (p = 0.0567). One UGT1A1 heterozygote died after a single dose of irinotecan due to irinotecan-related adverse effects. Identifying germline pharmacogenomic variants was feasible using whole-exome sequencing. Actionable pharmacogenetic variants are common and relevant to patients undergoing cancer treatment. Universal pharmacogenomic screening can be performed using whole-exome sequencing data originally obtained for quality control purposes and could be considered for patients who are candidates for irinotecan, 5-fluorouracil, capecitabine, and mercaptopurine." @default.
• W3198398959 created "2021-09-13" @default.
• W3198398959 creator A5000979293 @default.
• W3198398959 creator A5001730991 @default.
• W3198398959 creator A5008552495 @default.
• W3198398959 creator A5024211068 @default.
• W3198398959 creator A5030064179 @default.
• W3198398959 creator A5030194766 @default.
• W3198398959 creator A5039255086 @default.
• W3198398959 creator A5042110245 @default.
• W3198398959 creator A5044901389 @default.
• W3198398959 creator A5073422778 @default.
• W3198398959 creator A5074754509 @default.
• W3198398959 date "2021-09-08" @default.
• W3198398959 modified "2023-10-13" @default.
• W3198398959 title "Real-World Evaluation of Universal Germline Screening for Cancer Treatment-Relevant Pharmacogenes" @default.
• W3198398959 cites W1710752336 @default.
• W3198398959 cites W1969692023 @default.
• W3198398959 cites W1975760666 @default.
• W3198398959 cites W2049491341 @default.
• W3198398959 cites W2065874658 @default.
• W3198398959 cites W2071003201 @default.
• W3198398959 cites W2085025074 @default.
• W3198398959 cites W2085725038 @default.
• W3198398959 cites W2093274439 @default.
• W3198398959 cites W2103441770 @default.
• W3198398959 cites W2108234281 @default.
• W3198398959 cites W2121917437 @default.
• W3198398959 cites W2138509705 @default.
• W3198398959 cites W2141663748 @default.
• W3198398959 cites W2147670494 @default.
• W3198398959 cites W2155943701 @default.
• W3198398959 cites W2159226865 @default.
• W3198398959 cites W2190282709 @default.
• W3198398959 cites W2411762199 @default.
• W3198398959 cites W2417483443 @default.
• W3198398959 cites W2557981253 @default.
• W3198398959 cites W2626559810 @default.
• W3198398959 cites W2740881191 @default.
• W3198398959 cites W2770026599 @default.
• W3198398959 cites W2770862842 @default.
• W3198398959 cites W2774950305 @default.
• W3198398959 cites W2792737942 @default.
• W3198398959 cites W2883280903 @default.
• W3198398959 cites W2895355826 @default.
• W3198398959 cites W2900673338 @default.
• W3198398959 cites W2902777630 @default.
• W3198398959 cites W2903144991 @default.
• W3198398959 cites W2909725539 @default.
• W3198398959 cites W2924778985 @default.
• W3198398959 cites W2944434778 @default.
• W3198398959 cites W2978740330 @default.
• W3198398959 cites W3029661147 @default.
• W3198398959 cites W3048201616 @default.
• W3198398959 cites W3096109403 @default.
• W3198398959 cites W3135638642 @default.
• W3198398959 cites W3144007948 @default.
• W3198398959 doi "https://doi.org/10.3390/cancers13184524" @default.
• W3198398959 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8468204" @default.
• W3198398959 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34572750" @default.
• W3198398959 hasPublicationYear "2021" @default.
• W3198398959 type Work @default.
• W3198398959 sameAs 3198398959 @default.
• W3198398959 citedByCount "4" @default.
• W3198398959 countsByYear W31983989592022 @default.
• W3198398959 countsByYear W31983989592023 @default.
• W3198398959 crossrefType "journal-article" @default.
• W3198398959 hasAuthorship W3198398959A5000979293 @default.
• W3198398959 hasAuthorship W3198398959A5001730991 @default.
• W3198398959 hasAuthorship W3198398959A5008552495 @default.
• W3198398959 hasAuthorship W3198398959A5024211068 @default.
• W3198398959 hasAuthorship W3198398959A5030064179 @default.
• W3198398959 hasAuthorship W3198398959A5030194766 @default.
• W3198398959 hasAuthorship W3198398959A5039255086 @default.
• W3198398959 hasAuthorship W3198398959A5042110245 @default.
• W3198398959 hasAuthorship W3198398959A5044901389 @default.
• W3198398959 hasAuthorship W3198398959A5073422778 @default.
• W3198398959 hasAuthorship W3198398959A5074754509 @default.
• W3198398959 hasBestOaLocation W31983989591 @default.
• W3198398959 hasConcept C104317684 @default.
• W3198398959 hasConcept C10590036 @default.
• W3198398959 hasConcept C121608353 @default.
• W3198398959 hasConcept C126322002 @default.
• W3198398959 hasConcept C135763542 @default.
• W3198398959 hasConcept C143998085 @default.
• W3198398959 hasConcept C16671776 @default.
• W3198398959 hasConcept C170734499 @default.
• W3198398959 hasConcept C2778260677 @default.
• W3198398959 hasConcept C2779134260 @default.
• W3198398959 hasConcept C2780259306 @default.
• W3198398959 hasConcept C2908647359 @default.
• W3198398959 hasConcept C501734568 @default.
• W3198398959 hasConcept C526805850 @default.
• W3198398959 hasConcept C54355233 @default.
• W3198398959 hasConcept C55775858 @default.
• W3198398959 hasConcept C60644358 @default.
• W3198398959 hasConcept C70917649 @default.
• W3198398959 hasConcept C71924100 @default.

• next